http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-306608-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a30d6689e02c27c8d8f693bb2a11ecf1
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-447
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q3-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-44
filingDate 1964-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1965-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-306608-A1
titleOfInvention PROCEDURE FOR THE PREPARATION OF PRODUCTS AGAINST THE FRAGILITY OF THE NAILS
abstract S-Carboxymethylcysteine <FORM:1071807/C2/1> is prepared by alkylating cysteine with an alkali metal monochloroacetate, in the presence of a proton acceptor, preferably NaOH the reaction is carried out in aqueous solution at about 5 DEG C., under inert gas (nitrogen) and when complete the product is precipitated by acidifying the reaction mixture and recrystallized from alkaline solution by addition of acid. The product is afterwards converted to its sodium salt in aqueous solution, for use in a pharmaceutical composition (see Divisions A5-A6).ALSO:Pharmaceutical compositions for topical application comprise a water-in-oil emulsion of a solution of a non-toxic, water-soluble salt of S-carboxymethyl cysteine in an aqueous phase uniformly dispersed throughout a non-toxic topically applicable unguent lipid carrier as the non-aqueous phase. The composition preferably includes one or more surface active agents, such as polyoxyethylene sorbitan monooleate, alkali metal lauryl sulphonates, and triethanolamine stearate. The preferred soluble salts are those of alkali metals or ammonium organic bases such as mono-or tri-ethanolamine, or basic aminoacids such as lysine or arginine. The lipid medium may contain one or more of glyceryl mono-stearate or-palmitate, lanolin or hydrogenated lanolin, perhydrosqualene, polyethylene glycols, propylene glycol stearate, hydrogenated oils and mixed esters of glycerol and polyoxyethylene glycol obtained by subjecting oils such as almond p oil to alcoholysis in the presence of polyoxyethylene glycols, cholesterol or its palmitate, sorbital, preservatives, (benzalkonium chloride or sorbic acid), and suitable coloring agents. Other active ingredients may be present, such as thyroxin and vitamin A. The compositions are useful for treating fragility of human nails.
priorityDate 1963-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419565407
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551033
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8089
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5354043
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7618
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID504166
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5862
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1080
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517412
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445354
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425966266
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419529708
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14878
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557696
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483452
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557108
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547949
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590335
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547328
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426079173
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24699
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71308275
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25201348
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454518040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417430547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419514741
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3084463

Total number of triples: 50.